PLUS THERAPEUTICS, INC. Files 8-K
Ticker: PSTV · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
PLUS THERAPEUTICS, INC. filed an 8-K on 3/7/25 for 'Other Events'.
AI Summary
On March 7, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. The company's principal executive offices are located at 4200 Marathon Blvd., Suite 200, Austin, Texas 78756.
Why It Matters
This 8-K filing signals that PLUS THERAPEUTICS, INC. has reported significant events beyond routine disclosures, requiring investor attention.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for 'Other Events' without immediate disclosed financial impact or significant corporate changes.
Key Numbers
- 001-34375 — SEC File Number (Identifies the company's filing with the SEC.)
- 33-0827593 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- 4200 Marathon Blvd., Suite 200, Austin, Texas 78756 (location) — Principal executive offices
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
FAQ
What specific 'Other Events' are being reported by PLUS THERAPEUTICS, INC. in this 8-K filing?
The provided text of the 8-K filing does not detail the specific 'Other Events'; it only indicates that this is the item being reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 7, 2025.
What is the principal business address of PLUS THERAPEUTICS, INC.?
The principal executive offices of PLUS THERAPEUTICS, INC. are located at 4200 Marathon Blvd., Suite 200, Austin, Texas 78756.
What was the former name of PLUS THERAPEUTICS, INC. prior to its current name?
The filing indicates that the company was formerly known as CYTORI THERAPEUTICS, INC. and prior to that, MACROPORE INC.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).